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lipids and play an important role in the prevention of atelectasis.
The physiologically optimum length for the chains of both lecithin and phosphatidyl ethanolamine (that is, the length most eflicient in reducing surface tension in the lung) is 16 fully saturated carbon atoms (palmitic acid); future research should aim at stimulating the synthesis of these specific phospholipids in babies who have the respiratory distress syndrome.
Hyaline membrane disease of the newborn, which is known as the idiopathic respiratory distress syndronie (RDS) during life, is still a major cause of death in preterm babies (7) . A deficiency of pulmonary surfactant lining the alveoli has been associated with HMD (3, 25) and it has also been shown (1, 5) that babies who die of HMD have decreased amounts of lung lecithin.
Lung surfactant reduces surface tension in the alveoli and this prevents alveolar collapse. The surfactant contains large quantities of phospholipids, especially dipalmitoyl lecithin (4, 6, 8 , 11, 14, 24) , which are highly surface active. The chemical formulas of lecithin and phosphatidyl ethanolamine are shown in Figure 1 .
Increasing amounts of dipalmitoyl lecithin and other phospholipids appear in fetal lung surfactant with advancing gestation (8) . Recently there has been great interest in identifying these phospholipids, specifying their fatty acid chains, and tracing their biosynthetic pathways, since this knowledge may help in the management or prevention of hyaline membrane disease.
Kennedy and Weiss (20) first described the major biosynthetic pathways for lecithin (Fig. 2) . Pathway 1 is the phosphorylation of a-glycerophosphate by CDP-choline. Pathway 2 is the threestep methylation of PE with S-adenosyl methionine acting as the methyl donor. An internicdiary compound in this reaction is PDME. Pathway 3, the acylation of lysolecithin by pulmonary macrophages, has also recently been described (9, 17) .
Enzymic studies have demonstrated that pathway 1 is responsible for 9 7 % of lecithin production in the fetus. These have been reviewed by Farrell and Avery ( l o ) , who felt that the majority of the current evidence points to the fact that there is little activity of pathway 2 in the human fetal lung.
In biochemical studies, the fatty acid chains attached to the aand p-carbons of the surfactant phospholipids are analyzed and used as indicators of the biosynthetic pathways producing their formation (Fig. 2) . In the first of these studies in 1967, Gluck and coworkers (15) confirmed that pathway 1 was the major biosynthetic pathway in the fetal rabbit lung. In a later, similar study (13) , they found that myristic acid was the most prominent fatty acid on the p-carbon of PDME from alveolar wash (60% myristic). When large amounts of p-lecithin myristic acid were found in the pharyngeal aspirates of newborn babies (12) , this was taken as indicating that pathway 2 was active; the myristic acid was assumed to have originated from PDME.
There have therefore been conflicting results between enzymic and biochemical studies regarding the most important pathway in the fetus and neonate. This study was carried out to confirm Gluck's original biochemical studies in the human neonatal lung. In particular, it was to seek evidence for large quantities of myristic acid in pulnlonary lecithin and PDME.
METHODS

CLINICAL
The left lung was removed at postmortem examination from 23 newborn infants (Table 1) . Six infants had died from hyaline membrane disease (HMD), confirmed by histologic examination of the right lung.
LUNG WASH PROCEDURE
When removing the lungs, care was taken to keep a section of the pulmonary artery, bronchus, and trachea intact. The pulmonary artery was cannulated and 0.9% saline solution was flushed gently through the vascular system until the fluid draining from the pulmonary vein was free of blood. A tube was then inserted through the trachea into the bronchus and tied in position. Small portions of 0.9% saline were injected into the lung via the tracheal tube and the washings were collected and pooled. Phospholipids were extracted from these washings using the following procedure.
EXTRACTION AND SEPARATION
Duplicate 2-ml portions of the alveolar washes were extracted into chloroform-methanol (2:l) (29) . The extracted lipids were dried and concentrated in the bottom of a conical tube. These tubes were cooled in ice and ice-cold acetone added dropwise to the extract to precipitate the surface-active fraction (13) . After precipitation was complete, the acetone was decanted into another tube. The process was then repeated and the acetonesoluble fractions were pooled and evaporated. The precipitates were also dried under nitrogen. Phospholipids in both acetonesoluble and acetone-precipitated fractions were separated by thin layer chromotography and visualized in iodine vapor. Lecithin, PDME, and P E were scraped from the thin layer plates and eluted into chloroform-methanol (2:l). These extracts were used for: ( I ) separation and methylation of the P-fatty acid chains by incubation with the enzyme, phospholipase A , found in the venom of the snake, Naja naja (17, 30); ( 2 ) separation and methylation of both fatty acids chains by alkaline hydrolysis by a method modified from Warren et al. (26) .
GAS CHROMATOGRAPHY
The fatty acid methyl ester residues were dissolved in 20 p1 ethyl acetate and 3-p1 portions were injected into the column.
CONDITIONS FOR ANALYSIS
T h e apparatus used was a Perkin-Elmer F11 gas chromatograph (FID) with a 6 foot glass column packed with 15% diethylene glycol succinate (DEGS) on 80/100 Chromosorb WAW. The carrier gas was nitrogen at a flow rate of 25 ml/min. T h e isothermal temperature was 180" (31) .
Fatty acid methyl esters between 14 and 22 carbon chain length were identified and expressed as percentages of each other, thus giving proportions rather than actual concentrations. Twelve possible sets of results were obtained for each lung wash: a-and Pchains for both the acetone-soluble and acetone-precipitated fractions of lecithin, PDME, and PE.
RESULTS
LECITHIN
The results from the 17 non-HMD cases for acetone-precipitated lecithin are shown in Table 2 . There was an increase in 
P/M ratio: palmitic to myristic acid ratio; PIS ratio: palmitic to stearic acid ratio.
both a-and ppalmitic acid and total saturated fatty acids after 37 weeks of gestation (the range for palmitic acid was 22-76% before 32 weeks of gestation and 42-95% after 37 weeks). Individual amounts of myristic acid varied between 0 % and 1 4 % with no relationship to gestation as also reflected in the palmitic-myristic (P/M) ratio (Table 2) .
Fatty acids showing decreases during gestation were a-and / 3-oleic and p-stearic. The palmitic to stearic (PIS) ratio of the Pchain was higher after 37 weeks of gestation; there was little change in a-chain PIS ratios with gestation. Acetone-soluble lecithin showed similar variations to acetone-precipitated lecithin but with a slightly higher proportion of unsaturated fatty acids (data available on request).
PHOSPHATIDYL DIMETHYL ETHANOLAMINE AND PHOSPHATIDYL ETHANOLAMlNE
These two phospholipids had similar fatty acid chains. Most extracts had a high proportion of long chain, unsaturated fatty acids which were not identified. The proportions of identified fatty acids on the acetone-precipitated P D M E of the 17 non-HMD cases are shown in Table 3 .
The proportions of both a-and ppalmitic acid increased after 37 weeks of gestation (range 17-50% before 32 weeks, 24-92% after 37 weeks) but, on average, was not present in such large quantities as on the lecithin.
The highest individual amount of myristic acid was 26% but most extracts had much less than this (range 0-26%). Variations in stearic and oleic acids were similar to those of the lecithin fraction, although the variation in the PIS ratio was not so great. The proportion of saturated fatty acids (excluding unidentified long chain acids) was lower than on the lecithin fraction.
The acetone-soluble fraction contained very little PDME, P E , o r sphingomyelin so no comparisons could be drawn with the . -acetone-precipitated fraction:
HYALINE MEMBRANE DISEASE
The results for the six infants who died of hyaline membrane disease are shown in Table 4 . Palmitic acid was present in lower quantities on both acetone-precipitated and acetone-soluble Iecithin. The P/S ratio was also low. There was a higher percentage of unsaturated fatty acids and longer chain saturated fatty acids when compared with infants who did not have H M D . Higher concentrations of myristic acid were present in the acetoncsoluble fraction. P D M E was not present in any of the extracts.
When the (acetone-precipitated) lecithin results of the 1 3 liveborn babies were divided into H M D and non-HMD (7) cases, some interesting variations in palmitic acid were present (Fig. 3) , with the main differences on the p c h a i n . Logarithmic transformation of the data and application of a Student t-test showed that the H M D group had a significantly lower proportion of Plecithin palmitic acid (P < 0.05 > 0.02). Lecithin myristic acid showed little difference between the two groups.
EFFECTS OF EXTRAUTERINE SURVIVAL
In the group of non-HMD babies born before 2 8 weeks of gestation, five made n o attempt at spontaneous respiration and two survived for 3 1 and 9 5 hr before death (caused by intraventricular hemorrhage). These two babies (both female) had larger amounts of @palmitic acid on both lecithin and P D M E compared with the stillborn infants (Fig. 4) . T w o of the stillbirths P/M ratio: palmitic to niyristic acid ratio; P/S ratio: palmitic to stcaric acid ratio. Fig. 3 . Comparison between the major lecithin fatty acids in the lungs of non-hyaline membrane disease (non-HMD) and HMD babies. Fig. 4 . Proportion of /?-chain palmitie acid in lung phospholipids and its relationship to the respiratory status of the infants (non-hyaline membrane disease cases). PDME: phosphatidyl dimethylethanolamine. P/M ratio: palmitic to myristic acid ratio; PIS ratio: palmitic to stcaric acid ratio.
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were twins and their lecithin a-chains had similar proportions of palmitic acid (74 and 76%). O n the lecithin @chain the male twin had 1 3 % less palmitic acid than the female twin. This male1 female difference was not present when the results of the whole group of 1 7 non-HMD cases were analyzed.
DISCUSSION
LEClTHl N
This study confirms the findings (12, 27) that P D M E is not present in lung effluents of babies with RDS, and also that the level of lecithin palmitic acid is low in these infants. It does not confirm previous reports that P D M E has a high proportion of /3-myristic acid (13) nor that this high proportion of pnlyristic acid is present on the lecithin of normally breathing babies (12) .
Goerke and Clements (16) demonstrated that paln~itoyl, myristoyl lecithin has very little surface activity s o it is unlikely to be P D M E present in large quantities in the lungs of normally breathing infants. On the other hand, dipalmitoyl lecithin is extremely surface active (19, 23) and most probably plays a major role in preventing the lungs from collapse during respiration.
Phosphatidyl ethanolamine and sphingomyelin are also highly surface active (19) and increase in concentration in the lung during gestation ('1). Therefore, dipalmitoyl lecithin does not act in isolation but in coniunction with other lecithins. phospholipids, and surfactant proteins.
Enzymic studies indicate that 97% of lecithin synthesis in the fetal lung is by pathway 1 and it is only the much quoted studies of Gluck and coworkers that have led to the speculation that pathway 2 is active at some stages of gestation and after the onset of respiration.
In this study the comparison between the fatty acids of PDME and lecithin shows that it is unlikely that lecithin is formed by the P D M E route (pathway 2). The longer chain unsaturated acids present on the P D M E were rarely seen on the lecithin and the P D M E had fewer saturated acids than lecithin.
It has been suggested (22) that contamination of the snake venom o r the cheniicals used for extraction contributed to the apparently high proportions of myristic acid found in Gluck's studies. Contamination of laboratory reagents was a major problem in the early stages of our own study and it was eliminated by redistillation of the solvents used.
The increase in the PIS ratio towards term is interesting since the measurement of this ratio has been suggested as a test on amniotic fluid for the presence of fetal pulmonary surfactant (2).
It must be noted, however, that the array of fatty acids on all of the lung phospholipids shows considerable variation. Kerr and Helmuth (21) found high levels of stearic acid on the lung sphingomyelin of rhesus monkeys; this stearic acid would also be included in the amniotic fluid test. On this evidence the measurement of the L/S ratio of amniotic fluid is more likely to be accurate even though a false negative rate of 46% has bccn found with L/S ratios below 2.0 (18).
The differences observed in the proportion of palmitic acid on the phospholipids of breathing compared with stillborn infants were also present in infants born at later gestations (12% extra lecithin palmitic acid in the liveborn infants); these results were not included as some of the liveborn babies additionally developed pneumonia. A comparison of the stillbirths at all gestations with the five babies who breathed spontaneously and did not develop H M D or pneumonia shows that an 18% deficit of /3-lecithin palmitic acid was present in stillborn babies. Previous studies have found up to a 30-fold increase in surfactant production 1 hr after the onset of respiration (12) . These findings suggest that the onset of respiration not only stimulates the production of surfactant but also the synthesis of its most potent ingredient, dipalmitoyl lecithin.
CONCLUSION
It would seem from these studies that the key factor in the synthesis of surfactant phospholipids is the availability of palmitic acid and the ease of its incorporation into lecithin and PE. The synthetic pathways utilized are of secondary importance. Future research should be concerned with methods of promoting the production and availability of dipalmitoyl lecithin in the lungs of premature infants.
